Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 12
- +1 vs. Q3 2025
- Portfolio value
- $369.5M
- +$131.5M (+55.2%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Vanguard Ftse All-World Ex-US Index Fund922042775 | ETF | 2,990,084 | $220.0M | 59.5% | +411,900+16.0% | Added | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 520,000 | $99.3M | 26.9% | +520,000 | New | – |
| iShares MSCI India ETF46429B598 | ETF | 369,600 | $20.0M | 5.4% | 00.0% | Unchanged | – |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $8.50M | 2.3% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 989,410 | $8.09M | 2.2% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,627,643 | $3.28M | 0.9% | 00.0% | Unchanged | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 4,104 | $2.80M | 0.8% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 82,234 | $2.79M | 0.8% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 1,307,858 | $2.04M | 0.6% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 87,696 | $1.98M | 0.5% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,015,705 | $722.7K | 0.2% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 170,833 | $3.42K | <0.1% | 00.0% | Unchanged | – |